Clinical applications of hormonal therapy in ovarian cancer

Gautam G. Rao, David S. Miller

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

The ovary is an endocrine organ and an end organ. Hormones and their receptors have been associated with ovarian cancer and may be related to its causation. Some data suggest that hormonal therapies may have some effect on ovarian cancer in palliative settings. No hormonal therapy is approved by the US Food and Drug Administration (FDA) for the treatment of any type of ovarian malignancy nor is it listed as an active agent by any of the authoritative compendia. Because of the endocrine associations with ovarian cancer, the minimal side effects, and demonstrated activity of hormonal therapies in other endocrine-associated malignancies, further study is needed.

Original languageEnglish (US)
Pages (from-to)97-102
Number of pages6
JournalCurrent treatment options in oncology
Volume6
Issue number2
DOIs
StatePublished - Mar 2005

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Clinical applications of hormonal therapy in ovarian cancer'. Together they form a unique fingerprint.

  • Cite this